Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company is developing cannabis strains optimized for tropical climates with research partnerships focused on seed genetics and nanotechnology to enhance cannabinoid bioavailability. It has established greenhouses compliant with FDA standards in Thailand aiming at producing medicinal-grade THC flowers supplied to government health departments.
Clinical data or advanced trial results are not available; activities appear focused on R&D and regulatory approvals.
Pipeline breadth appears limited primarily to cannabis cultivation/extraction programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AABio Technologies.